Northwire Canada EditionSaturday, July 11, 2026
Sign inSubscribe
Northwire
⌕
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
Financings Routine +

Mountain Valley MD Announces Closing of Non-Brokered Private Placement of Units and Concurrent Shares for Debt Transactions

MVMD Closes Financing to Fuel Agrarius Commercialization Amid Dilutive Share Issuance

By The Northwire Desk — AI Analysis Apr 15, 2026 · 08:00 MVMD · 0.05 Mountain Valley MD Holdings Inc.
Executive Summary
  • Mountain Valley MD Holdings Inc. (MVMD) announced the closing of a non-brokered private placement on April 15, 2026.
  • The company raised CAD $2,000,000 in gross proceeds by issuing 80,000,000 units at CDN $0.025 per unit.
  • Each unit consists of one common share and one common share purchase warrant exercisable at CDN $0.08 for 12 months.
  • Concurrently, MVMD settled CAD $485,000 in outstanding debt through "shares for debt" transactions (22,647,058 shares at $0.017 and 2,000,000 shares at $0.05).
  • The financing was previously announced on March 31, 2026, with closing expected in April 2026.
  • Proceeds are designated for general working capital purposes to support ongoing operations.
  • Securities are subject to a four-month and one-day hold period expiring August 15, 2026.
Material Impact
  • The financing confirms the execution of the March 31 announcement; therefore, it contains no new unexpected information regarding terms or amounts.
  • Raising CAD $2 million provides immediate liquidity to fund commercialization efforts highlighted in December 2025 updates (Agrarius trials).
  • Debt settlement via equity issuance reduces balance sheet liabilities but increases share count dilution significantly.
  • The unit price of $0.025 is extremely low, indicating the company's valuation remains at penny stock levels despite positive operational data from Brazil citrus trials (+49% yield increase).
  • Warrant acceleration clause (triggered if CSE VWAP >= $0.12 for 10 days) creates a potential future dilution event if the stock rallies significantly above current levels.
  • The transaction is categorized as Routine - Positive because it was fully disclosed in advance and represents standard capital raising behavior for early-stage biotech/agri-tech firms.
MVMD · Price
Company Overview
  • Mountain Valley MD Holdings Inc. operates across three core platforms: Quicksome (nutraceuticals), Agrarius (agricultural signaling), and Soluvec (animal husbandry/aquatic).
  • Flagship Project: Agrarius, a plant-signaling additive showing significant yield improvements in Brazil citrus trials (+15% to +49%).
  • Quicksome holds exclusive manufacturing/licensing with Circadian Wellness for sublingual products ("Eons Dialed", "Eons Deeper Sleep").
  • Soluvec is an ivermectin formulation licensed in Bangladesh, though revenue has been impacted by market disruptions.
  • Company focuses on low-capital, royalty-based arrangements to expand asset portfolio without heavy operational overhead.
Read the original news release →

More from Mountain Valley MD Holdings Inc.

May 29, 2026 · 08:30

MVMD Advances Peptide Platform Ahead of July FDA Catalyst, Balance Sheet Fortified by Recent Financing

Production / Operations Mar 31, 2026 · 18:23

Mountain Valley arranges offering, two debt settlements

Financings Mar 31, 2026 · 08:30

MVMD Secures $2M Lifeline at Steep Discount as Warrant Strike Aligns with Recent Price Spike

Financings Mar 02, 2026 · 18:55

SEDAR Interim Financial Statements

None Dec 24, 2025 · 17:55

Mountain Valley MD Provides Year-End Business Update, Advances Commercialization Across Core Platforms

Production / Operations Dec 01, 2025 · 17:45

Mountain Valley MD Confirms Positive Agrarius Agricultural Trial Results, Advancing Toward Commercialization

Production / Operations